HITV Lab

Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

Tuesday12 December 2017

The Star : A newer approach to cancer treatment

Blogger

HOSPITAL Universiti Kebangsaan Malaysia (HUKM) is currently carrying out a small trial utilising a form of immunotherapy called Human Initiated Therapeutic Vaccine (HITV).

In the trial, HITV is used in combination with modulated radiotherapy to treat advanced stage (metastatic) cancers.

HITV is pioneered by Hasumi International Research Foundation’s Dr Kenichiro Hasumi.

It involves the use of dendritic cells to stimulate an immune system response to cancer.

The dendritic cells are harvested from the patient and cultured in a laboratory.

Read more ...

Subcategories

HITV Lab

HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks